Graphene Nanochem Regulatory News (GRPH)

31 Aug 2007 08:38

Biofutures International plc31 August 2007 For Immediate Release 31 August 2007 Biofutures International plc ('Biofutures' or 'the Company') Total Voting Rights For the purposes of the Financial Services Authority's Disclosure andTransparency Rules, the Company notifies the market of the following: As at the date of this announcement, the Company's issued share capital consistsof 151,060,000 ordinary shares with a nominal value of 1 pence each ("OrdinaryShares"), with voting rights. The Company does not hold any Ordinary Shares inTreasury. Therefore, the total number of Ordinary Shares with voting rights is151,060,000. The above figure of 151,060,000 Ordinary Shares may be used by shareholders inthe Company as the denominator for the calculations by which they will determineif they are required to notify their interest in, or a change in their interestin, the share capital of the Company under the FSA's Disclosure and TransparencyRules. For further information: Julie Pomeroy, Finance DirectorBiofutures International Plc 020 7466 5000 Joseph Marffy/Roxane MarffyRuegg & Co Limited 020 7584 3663 Daniel Briggs/Jeremy ChantryHichens Harrison & Co plc 020 7382 7776 Suzanne Brocks 0207 466 5000Buchanan Communications This information is provided by RNS The company news service from the London Stock Exchange